Lilly Price Prediction: Case for Double-Digit Upside
Eli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
This comparison highlights essential contrasts between Zero Based and Incremental budgeting, focusing on allocation, rigor, and outcomes.
17,319 articlesEli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
A new study links AI spending to increased hiring in large U.S. firms, suggesting productivity gains precede payroll ...
A direct clash between a political figure and the Federal Reserve can shake markets. This article breaks down what ha...
Analysts publish a broad slate of Wednesday notes, highlighting opportunities across metals, energy, consumer staples...
A new Fidelity analysis finds that most 401(k) savers reach the $100,000 mark in their early 40s. The article explain...
Ciena’s shares jumped sharply in the first half of 2026. This article dives into the AI-driven demand for optical net...
XRP fell near $1.08 as big-money moves on the XRP Ledger quieted and ETF flows turned negative, underscoring a cautio...
As the Iran conflict intensified in early 2026, gold failed to rally as expected. A hypothetical $10,000 in gold woul...
Jim Cramer challenges a fresh downgrade on Apple, arguing the stock’s AI ambitions and a possible 2027 supercycle jus...
Pi Network's Core Team rolled out a major redesign of the mining app and Pioneer profile page, promising clearer navi...
Apple rides a fresh all-time high as HSBC analysts turn bullish, lifting targets and signaling more upside. Services ...
A mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...